HomeNAVBQ • OTCMKTS
add
Navidea Biopharmaceuticals Inc
Previous close
$0.00010
Day range
$0.00010 - $0.00020
Market cap
20.02K USD
Avg Volume
42.04K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 65.65K | -87.65% |
Operating expense | 11.33M | -10.01% |
Net income | -15.18M | -29.38% |
Net profit margin | -23.12K | -947.43% |
Earnings per share | — | — |
EBITDA | -11.36M | 5.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.00M | -52.83% |
Total assets | 4.37M | -34.21% |
Total liabilities | 12.51M | 107.89% |
Total equity | -8.14M | — |
Shares outstanding | 32.76M | — |
Price to book | -0.00 | — |
Return on assets | -129.93% | — |
Return on capital | 330.30% | — |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | -15.18M | -29.38% |
Cash from operations | -8.99M | 12.05% |
Cash from investing | -390.35K | -18.49% |
Cash from financing | 7.14M | -41.01% |
Net change in cash | -2.24M | -243.24% |
Free cash flow | -2.29M | 35.77% |
About
Founded
1983
Headquarters
Website
Employees
11
